DAA1030 |
Arthritis (Male) |
Pathological |
cartilage |
Human |
— |
SeriesIncidence |
|
DAA1031 |
Arthritis (Female) |
Pathological |
cartilage |
Human |
— |
SeriesIncidence |
|
DAA1992 |
Muscle mass and strength loss |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA2026 |
Mutations in mitochondrial DNA accumulate |
Physiological |
heart, kidney, skeletal muscle, cerebral cortex, cerebellum |
Human |
— |
— |
|
DAA2040 |
Reduced type II muscle fiber |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA2045 |
Loss of muscle torque |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA2056 |
MicroRNA let-7b expression upregulated |
Molecular |
skeletal muscle |
Human |
— |
— |
|
DAA2057 |
MicroRNA let-7e expression upregulated |
Molecular |
skeletal muscle |
Human |
— |
— |
|
DAA2591 |
Advanced glycation end products increases in aging human skeletal muscle |
Physiological |
muscle |
Human |
— |
— |
|
DAA2592 |
Muscle characteristics change with aging |
Physiological |
muscle |
Human |
— |
— |
|
DAA2599 |
Telomere shortening |
Physiological |
adipose tissue, skeletal muscle, skin, leukocyte |
Human |
— |
— |
|
DAA292 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa |
Molecular |
skeletal muscle |
Human |
NDUFA9 |
3.0% Decrease Gene Expression Level |
|
DAA293 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 |
Molecular |
skeletal muscle |
Human |
DDX24 |
3.0% Increase Gene Expression Level |
|
DAA294 |
RNA terminal phosphate cyclase domain 1 |
Molecular |
skeletal muscle |
Human |
RTCD1 |
3.0% Decrease Gene Expression Level |
|
DAA295 |
hypothetical protein DKFZp586I1420 |
Molecular |
skeletal muscle |
Human |
— |
7.0% Increase Gene Expression Level |
|
DAA296 |
golgi apparatus protein 1 |
Molecular |
skeletal muscle |
Human |
GLG1 |
6.0% Increase Gene Expression Level |
|
DAA297 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
Molecular |
skeletal muscle |
Human |
GOT2 |
4.0% Decrease Gene Expression Level |
|
DAA298 |
malate dehydrogenase 2, NAD (mitochondrial) |
Molecular |
skeletal muscle |
Human |
MDH2 |
2.0% Decrease Gene Expression Level |
|
DAA299 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
Molecular |
skeletal muscle |
Human |
ATPAF1 |
2.0% Decrease Gene Expression Level |
|
DAA300 |
discs, large homolog 5 (Drosophila) |
Molecular |
skeletal muscle |
Human |
DLG5 |
4.0% Increase Gene Expression Level |
|
DAA301 |
sperm associated antigen 9 |
Molecular |
skeletal muscle |
Human |
SPAG9 |
4.0% Increase Gene Expression Level |
|
DAA302 |
growth hormone inducible transmembrane protein |
Molecular |
skeletal muscle |
Human |
GHITM |
3.0% Decrease Gene Expression Level |
|
DAA303 |
FK506 binding protein 1A, 12kDa |
Molecular |
skeletal muscle |
Human |
FKBP1A |
3.0% Decrease Gene Expression Level |
|
DAA304 |
family with sequence similarity 162, member A |
Molecular |
skeletal muscle |
Human |
FAM162A |
3.0% Decrease Gene Expression Level |
|
DAA305 |
chemokine-like factor |
Molecular |
skeletal muscle |
Human |
CKLF |
4.0% Increase Gene Expression Level |
|